EU research projects

IDF Europe welcomes the opportunity to take an active role in EU-funded research and other initiatives that aim at improving the health of European citizens, as these contribute to finding new treatments for diabetes and improving the lives of people living with this condition.

Developed within the EU Seventh Framework Programme (FP7) and Horizon 2020 research and innovation programme, these projects encourage the development and validation of new therapies, methods for health promotion and prevention, as well as sustainable and efficient healthcare systems. IDF Europe is currently involved in the following projects: EuRhythdia, ePredice and Feel4diabetes

  • FEEL4DIABETES

    Feel4diabetes (Families across Europe following a healthy lifestyle 4 diabetes prevention) is a EU-funded project aiming to develop, implement and evaluate an evidence-based and potentially cost-effective and scalable intervention programme to prevent type 2 diabetes across Europe, primarily focusing on families 

    from vulnerable groups. The project spans the period 2014 to 2019 and is carried out by a multidisciplinary team of 10 partners across the EU.
    The project focuses on families because risk factors associated with type 2 diabetes tend to cluster within a family given that its members share common genetic background, lifestyle habits, social and physical environment. Promoting healthy behaviours and supportive environmental changes when the family is approached as a whole seems to be more effective compared to targeting the family members individually.

    Feel4Diabetes is implemented in two high-income countries (Belgium and Finland), two countries under economic crisis (Greece and Spain) and two low/middle-income countries (Bulgaria and Hungary).

    IDF Europe’s role in the project is to facilitate events and workshops for the advisory board and partners and to disseminate activities and results with the aim of embedding the learnings derived from the project into policies and practices at the local, national and international level.

    Principal investigator: Assoc Prof Dr Yannis Manios

  • EURHYTHDIA - LIFESTYLE AND DIABETES

    Evidence has accumulated that disruption of our body’s internal clock (the so-called circadian clock) might contribute to the development of Type 2 diabetes and other cardiometabolic complications.

    Few studies have investigated the link between the disruption of the daily sleep-wake pattern and Type 2 diabetes in man. For this reason, a multi-disciplinary consortium of leading academic experts and research-intensive SME’s have joined forces under EuRhythDia, the Consortium on chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population. This 5-year project will look at whether lifestyle change to reset the internal clock can significantly reduce the risk of developing Type 2 diabetes and cardiometabolic complications. 

    Principal investigator: Prof Rainer Böger

    Upcoming event(s):

    IDF E will organise a dissemination event at the end of June in Amsterdam, the Netherlands. Stay tuned for more info in the coming weeks!

  • JOINT ACTION ON CHRONIC DISEASES – CHRODIS

    The purpose of this Joint Action is to identify, exchange, scale-up and transfer best practices and effective interventions for chronic diseases, with a specific focus on health promotion and prevention, multi-morbidity and diabetes. 

    Health   promotion and prevention focuses on behavioural risk factors, social determinants and inequalities in health. Work on multi-morbidity focuses on multi- disciplinary and integrated care, patient safety and professional training. Diabetes is being used as a case study and looks into primary prevention through to treatment, with a specific focus on national diabetes plans.

    IDF Europe is specifically involved in Work Package 7 which takes Diabetes as a case study on strengthening health care for people with chronic diseases. WP7 focuses on  aspects  of  primary  prevention,  identification  of  people  at  high  risk,  early  diagnosis,  secondary prevention, and comprehensive multifactorial care (all for type 2 diabetes). There is also an focus on the development of national diabetes plans. A Platform of Knowledge Exchange (PKE) will be develop to house all the best practices identified through the Joint Action.

    Click here to get an overview of 2015 activities and 2016 activities across all Joint Action Work Packages.

© 2017 International Diabetes Federation Disclaimer